Literature DB >> 17346204

Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle.

Jianping Ye1.   

Abstract

Insulin resistance is a pathophysiological link of obesity to type 2 diabetes. The initial cause of insulin resistance is critical for prevention and treatment of type 2 diabetes. Lipotoxicity is a well-known concept in the explanation of initiation of insulin resistance. Although there are several prevailing hypotheses about the cellular/molecular mechanisms of lipotoxicity, such as inflammation, oxidative stress, hyperinsulinemia, and ER stress, the relative importance of these hypothesized events remains to be determined. The role of hyperinsulinemia is relatively under documented in the literature for the initiation of insulin resistance. In this review, an interaction of fatty acid and beta-cells, and a synergy between free fatty acids (FFAs) and insulin are emphasized for the role of hyperinsulinemia. This article presents the evidence about FFA-induced insulin secretion in vitro and in vivo, recent advances in the molecular mechanism of FFA action in beta-cells, a role of GPR40 in the development of insulin resistance, and the negative feedback loop of the insulin receptor signal pathway. The negative feedback loop is discussed in detail with a focus on IRS-1 serine kinases. This article provides a substantial support for the role of insulin in the early stages of FFA-associated insulin resistance. The hypothesis of insulin's role in lipotoxicity is referred to as the "insulin hypothesis" in this review. According to this hypothesis, prevention of increased beta-cell response to glucose may be a potential approach for early intervention of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346204     DOI: 10.2174/187153007780059423

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  31 in total

1.  Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance.

Authors:  Hui-Yu Liu; Tao Hong; Ge-Bo Wen; Jianmin Han; Degen Zuo; Zhenqi Liu; Wenhong Cao
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-28       Impact factor: 4.310

Review 2.  Regulation of stem cell differentiation in adipose tissue by chronic inflammation.

Authors:  Jianping Ye; Jeffery M Gimble
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-12       Impact factor: 2.557

Review 3.  Mechanisms of insulin resistance in obesity.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

Review 4.  The biochemical alterations underlying post-burn hypermetabolism.

Authors:  Christopher Auger; Osai Samadi; Marc G Jeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-20       Impact factor: 5.187

Review 5.  Insulin sensitivity and complications in type 1 diabetes: New insights.

Authors:  Petter Bjornstad; Janet K Snell-Bergeon; Kristen J Nadeau; David M Maahs
Journal:  World J Diabetes       Date:  2015-02-15

6.  Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.

Authors:  Manju Sharma; Fumihiko Urano; Anja Jaeschke
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

Review 7.  Mechanism of insulin resistance in obesity: a role of ATP.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

8.  S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.

Authors:  Jin Zhang; Zhanguo Gao; Jun Yin; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

9.  Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin.

Authors:  Hui-Yu Liu; Qu Fan Collins; Fatiha Moukdar; Degen Zhuo; Jianmin Han; Tao Hong; Sheila Collins; Wenhong Cao
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

10.  Mitochondrial inhibitor as a new class of insulin sensitizer.

Authors:  Yong Zhang; Jianping Ye
Journal:  Acta Pharm Sin B       Date:  2012-08       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.